Retatrutide

Retatrutide is a synthetic peptide under investigation as a multi-receptor agonist, commonly described as engaging GLP-1, GIP, and glucagon receptor pathways. Its structure is designed to combine incretin-like signalling with additional metabolic pathway engagement, making it a prominent tool compound in modern metabolic research. Mechanistic discussion typically centres on receptor-mediated signalling that influences glucose-dependent insulin secretion, gastric motility signals, appetite regulation circuits, and energy expenditure pathways. Preclinical and clinical research evaluates endocrine biomarkers, metabolic outputs, and tolerability profiles to characterise how combined receptor agonism shapes systemic metabolic signalling.

‍

‍

‍

‍

‍

‍

‍

‍

‍

‍

‍